Literature DB >> 8692382

Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas.

E Pozzati1, N Acciarri, F Tognetti, F Marliani, F Giangaspero.   

Abstract

In a series of 145 patients with brain cavernous angiomas treated at our hospital in the last 16 years, the angiomas of 18 patients exhibited aggressive biological behavior characterized by recurrent overt bleeding, growth, or de novo appearance. The cavernomas were in the cerebellum in three patients, in the brain stem in one, in the thalamus in four, in the caudate nucleus in two, in the diencephalon in one, and in the white matter of the cerebral hemispheres in seven. Three of these patients suffered from the familial or multiple form of the disease, two were pregnant, three had previously been irradiated for other tumors, and one had been treated by radiosurgery in the past. Overall, new cavernous malformations not previously shown were discovered in six patients. In 10 patients (3 male and 7 female) presenting with recurrent hemorrhages, the mean period of time between bleedings was 11 months (range, 1 wk-3 yr). Eleven patients were treated by definitive surgery, and seven were conservatively treated. One patient with a diencephalic cavernoma died from progressive hypothalamic dysfunction; three patients in the nonsurgical group had repeated symptoms and were left with additional neurological deficits. The outcome of the surgical group was the same (seven patients) or improved (four patients). Risk factors favoring an aggressive behavior included pregnancy, familial or multiple form of the disease, previous whole brain or stereotactic radiotherapy, incomplete removal, brain location, and associated venous malformation. The female preponderance (female to male ratio, 13:5) may also suggest some role of hormonal factors in influencing the biological behavior of cavernous malformations.

Entities:  

Mesh:

Year:  1996        PMID: 8692382

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  34 in total

1.  Molecular recognition of leucine-aspartate repeat (LD) motifs by the focal adhesion targeting homology domain of cerebral cavernous malformation 3 (CCM3).

Authors:  Xiaofeng Li; Weidong Ji; Rong Zhang; Ewa Folta-Stogniew; Wang Min; Titus J Boggon
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

Review 2.  Management of hemorrhage from cavernous malformations.

Authors:  Sachin Batra; Karen Rigamonti; Daniele Rigamonti
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

Review 3.  Cystic cavernous angiomas.

Authors:  Shigeo Ohba; Kazuhiko Shimizu; Syunsuke Shibao; Toru Nakagawa; Hideki Murakami
Journal:  Neurosurg Rev       Date:  2010-02-20       Impact factor: 3.042

Review 4.  Cavernous malformations: natural history, diagnosis and treatment.

Authors:  Sachin Batra; Doris Lin; Pablo F Recinos; Jun Zhang; Daniele Rigamonti
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

5.  Ultra-high-resolution C-arm flat-detector CT angiography evaluation reveals 3-fold higher association rate for sporadic intracranial cavernous malformations and developmental venous anomalies: a retrospective study in consecutive 58 patients with 60 cavernous malformations.

Authors:  Burak Kocak; Osman Kizilkilic; Buge Oz; Dogu Vuralli Bakkaloglu; Cihan Isler; Naci Kocer; Civan Islak
Journal:  Eur Radiol       Date:  2016-09-21       Impact factor: 5.315

6.  Nuclear Localization of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP1) Influences β1 Integrin Activation and Recruits Krev/Interaction Trapped-1 (KRIT1) to the Nucleus.

Authors:  Kyle M Draheim; Clotilde Huet-Calderwood; Bertrand Simon; David A Calderwood
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

7.  Multiple de novo vascular malformations in relation to diffuse venous occlusive disease: a case report.

Authors:  H A Desal; S K Lee; B S Kim; S Raoul; M Tymianski; K G TerBrugge
Journal:  Neuroradiology       Date:  2005-01-15       Impact factor: 2.804

8.  Cerebral cavernous malformation: a diagnostic challenge in a young patient with intracerebral haemorrhage.

Authors:  Kristijonas Milinis; Mohammed Mohammed; James Edward Dyer; Paul Anthony Sutton
Journal:  BMJ Case Rep       Date:  2012-07-25

9.  Biological activity of paediatric cerebral cavernomas: an immunohistochemical study of 28 patients.

Authors:  Wuttipong Tirakotai; Sandra Fremann; Niels Soerensen; Wolfgang Roggendorf; Adrian M Siegel; Hans Dieter Mennel; Yuan Zhu; Helmut Bertalanffy; Ulrich Sure
Journal:  Childs Nerv Syst       Date:  2006-02-18       Impact factor: 1.475

10.  Hemispheric venous dysgenesis in a woman presenting with seizures, weakness and parkinsonism.

Authors:  Deep Das; Michihiro Tanaka; Biman Kanti Roy; Vineeta Singh
Journal:  BMJ Case Rep       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.